Download PDF
J Pediatr Genet 2022; 11(02): 087-090
DOI: 10.1055/s-0040-1721678
Original Article

Rare Treatable Cause of Demyelinating Leukoencephalopathy That One Cannot Afford to Miss

Vykuntaraju K. Gowda
1   Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bengaluru, Karnataka, India
,
Sukanya Vignesh
1   Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bengaluru, Karnataka, India
,
Balamurugan Nagarajan
1   Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bengaluru, Karnataka, India
,
Varunvenkat M. Srinivasan
1   Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bengaluru, Karnataka, India
,
Manojna Battina
1   Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bengaluru, Karnataka, India
,
Maya Bhat
2   Department of Neuroradiology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
,
Rita Christopher
3   Department of Neurochemistry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
› Author Affiliations Funding None.
› Further Information
Also available at
    Permissions and Reprints

Abstract

Biotinidase deficiency is a treatable neurometabolic disorder. It usually presents during the first year of life with seizures, ataxia, hypotonia, vision and hearing disturbance, alopecia, and skin rashes. It can have various neuroimaging findings but demyelinating leukoencephalopathy is an unusual finding in children with biotinidase deficiency that can cause diagnostic challenge as it can radiologically mimic perinatal hypoxic–ischemic encephalopathy or other leukodystrophies. It reverses with early diagnosis and treatment with biotin supplementation and the outcome is rewarding.

Keywords

leukoencephalopathy - demyelination - biotinidase - neurometabolic disorders

Authors' Contributions

V.K. was involved in the supervision, guidance, and review of the manuscript. S.S. given valuable inputs in the management of this child. B.N. was involved in the management of the child and the preparation of the manuscript. M.B. has helped in diagnosis and the preparation of the manuscript. R.C. has helped in diagnosis and the preparation of the manuscript.


Ethical Approval

Ethical approval was obtained from Institute Ethical Committee, Indira Gandhi Institute of Child Health, Bengaluru.




Publication History

Received: 12 July 2020

Accepted: 03 November 2020

Article published online:
18 December 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Wolf B. Disorders of biotin metabolism. In: Scriver CR, Beaudet AL, Valle D. eds. The Metabolic and Molecular Bases of Inherited Disease. 8th edition. New York: McGraw-Hill; 2001: 3935-3962
    Google Scholar
  • 2 Wolf B, Spencer R, Gleason T. Hearing loss is a common feature of symptomatic children with profound biotinidase deficiency. J Pediatr 2002; 140 (02) 242-246
    CrossrefPubMedGoogle Scholar
  • 3 Navarro PC, Guerra A, Alvarez JG, Ortiz FJ. Cutaneous and neurologic manifestations of biotinidase deficiency. Int J Dermatol 2000; 39 (05) 363-365
    CrossrefPubMedGoogle Scholar
  • 4 Cowan TM, Blitzer MG, Wolf B. Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee. Technical standards and guidelines for the diagnosis of biotinidase deficiency. Genet Med 2010; 12 (07) 464-470
    CrossrefPubMedGoogle Scholar
  • 5 Wolf B. The neurology of biotinidase deficiency. Mol Genet Metab 2011; 104 (1-2): 27-34
    CrossrefPubMedGoogle Scholar
  • 6 Grünewald S, Champion MP, Leonard JV, Schaper J, Morris AAM. Biotinidase deficiency: a treatable leukoencephalopathy. Neuropediatrics 2004; 35 (04) 211-216
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Desai S, Ganesan K, Hegde A. Biotinidase deficiency: a reversible metabolic encephalopathy. Neuroimaging and MR spectroscopic findings in a series of four patients. Pediatr Radiol 2008; 38 (08) 848-856
    CrossrefPubMedGoogle Scholar
  • 8 Allen RJ, Wolf B, Grier RE. Infantile seizures in biotinidase deficiency. Ann Neurol 1983; 2: 386
    PubMedGoogle Scholar
  • 9 Wolf B. Biotinidase deficiency: “if you have to have an inherited metabolic disease, this is the one to have.”. Genet Med 2012; 14 (06) 565-575
    CrossrefPubMedGoogle Scholar